Contract for an Atypical Silent PartnershipProteo Inc • November 3rd, 2011 • Non-operating establishments
The Owner operates a commercial business in Kiel. The purpose of the entrepreneur is the development, manufacturing and marketing of pharmaceuticals. Prof. Wiedow intends to participate as an atypical silent partner (in the meaning of §§ 230 et. seq. of the German Commercial Code) in the business of the Owner in order to strengthen the equity. To that end the parties agree as follows:
LICENSE AGREEMENTLicense Agreement • November 3rd, 2011 • Proteo Inc • Non-operating establishments
This agreement, entered into effective as of December 30, 2000, by and between Proteo, Inc., a Nevada Corporation having its principal place of business at 2775 Mesa Verde Drive East, #F101, Costa Mesa, California 92626 (hereinafter the "Licensee"), and Professor Dr. med. Oliver Wiedow, MD, living at Forstweg 55, D-24105 Kiel, Germany,(hereinafter the "Licensor").
FORBEARANCE AGREEMENT AND GENERAL RELEASEForbearance Agreement and General Release • November 3rd, 2011 • Proteo Inc • Non-operating establishments • California
THIS FORBEARANCE AGREEMENT AND GENERAL RELEASE (“Agreement”), dated as of July 6th, 2009, is entered by and among FIDEsprit AG, a Swiss corporation (“ Borrower ”), Axel J. Kutscher (“ Guarantor ”) and Proteo, Inc., a Nevada corporation (“ Proteo ” and together with Borrower and Guarantor, the “ Parties ”), with reference to the facts as set forth in the Recitals:
Att: Chief Executive OfficerProteo Inc • November 3rd, 2011 • Non-operating establishments
This is to confirm certain agreements and understandings reached between me and Proteo, Inc. in December 2010 based on the following background:
PROTEO, INC. PREFERRED STOCK PURCHASE AGREEMENTPreferred Stock Purchase Agreement • November 3rd, 2011 • Proteo Inc • Non-operating establishments • California
This Preferred Stock Purchase Agreement ("Agreement") is made this 9th day of June, 2008 by and between PROTEO, INC., a Nevada corporation with its principal place of business at 2102 Business Center Drive, Irvine, CA 92612 (the "Company") and the Purchaser of its stock, FIDEsprit AG, a Swiss corporation with its principal place of business at Rosengartenstr. 4, CH-8608 Bubikon, Switzerland ("Purchaser").
